1. Cell Biology
  2. Neuroscience

Enhanced FIB-SEM systems for large-volume 3D imaging

  1. C Shan Xu  Is a corresponding author
  2. Kenneth J Hayworth
  3. Zhiyuan Lu
  4. Patricia Grob
  5. Ahmed M Hassan
  6. José G García-Cerdán
  7. Krishna K Niyogi
  8. Eva Nogales
  9. Richard J Weinberg
  10. Harald F Hess
  1. Janelia Research Campus, Howard Hughes Medical Institute, United States
  2. Howard Hughes Medical Institute, University of California, Berkeley, United States
  3. Howard Hughes Medical Institute, University of California, Berekely, United States
  4. University of North Carolina, United States
https://doi.org/10.7554/eLife.25916
Share this article
Cite this article
  1. C Shan Xu
  2. Kenneth J Hayworth
  3. Zhiyuan Lu
  4. Patricia Grob
  5. Ahmed M Hassan
  6. José G García-Cerdán
  7. Krishna K Niyogi
  8. Eva Nogales
  9. Richard J Weinberg
  10. Harald F Hess
(2017)
Enhanced FIB-SEM systems for large-volume 3D imaging
eLife 6:e25916.
https://doi.org/10.7554/eLife.25916
  2. Download BibTeX
  3. Download .RIS

Abstract

Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) can automatically generate 3D images with superior z-axis resolution, yielding data that needs minimal image registration and related post-processing. Obstacles blocking wider adoption of FIB-SEM include slow imaging speed and lack of long-term system stability, which caps the maximum possible acquisition volume. Here we present techniques that accelerate image acquisition while greatly improving FIB-SEM reliability, allowing the system to operate for months and generating continuously imaged volumes > 106 µm3. These volumes are large enough for connectomics, where the excellent z resolution can help in tracing of small neuronal processes and accelerate the tedious and time-consuming human proofreading effort. Even higher resolution can be achieved on smaller volumes. We present example data sets from mammalian neural tissue, Drosophila brain, and Chlamydomonas reinhardtii to illustrate the power of this novel high-resolution technique to address questions in both connectomics and cell biology.

Article and author information

Author details

  1. C Shan Xu

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    For correspondence
    xuc@janelia.hhmi.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8564-7836

  2. Kenneth J Hayworth

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    The authors declare that no competing interests exist.

  3. Zhiyuan Lu

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Patricia Grob

    Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  5. Ahmed M Hassan

    Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. José G García-Cerdán

    Department of Plant and Microbial Biology, Howard Hughes Medical Institute, University of California, Berekely, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  7. Krishna K Niyogi

    Department of Plant and Microbial Biology, Howard Hughes Medical Institute, University of California, Berekely, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.

  8. Eva Nogales

    Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9816-3681

  9. Richard J Weinberg

    Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.

  10. Harald F Hess

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    The authors declare that no competing interests exist.

Funding

Howard Hughes Medical Institute

  • C Shan Xu
  • Kenneth J Hayworth
  • Zhiyuan Lu
  • Krishna K Niyogi
  • Eva Nogales
  • Harald F Hess

U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division (SISGRKN)

  • Krishna K Niyogi
  • Eva Nogales

Gordon and Betty Moore Foundation (GBMF3070)

  • Krishna K Niyogi

NIH (R01 NS-039444)

  • Richard J Weinberg

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jeremy Nathans, Johns Hopkins University School of Medicine, United States

Ethics

Animal experimentation: All of the vertebrate animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#13-258.0) of UNC. UNC's PHS Assurance number is D16-00256 (A3410-01); the AALAC Unit number is 000329.

Version history

  1. Received: February 10, 2017
  2. Accepted: May 9, 2017
  3. Accepted Manuscript published: May 13, 2017 (version 1)
  4. Accepted Manuscript updated: May 16, 2017 (version 2)
  5. Version of Record published: June 19, 2017 (version 3)

Copyright

© 2017, Xu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 24,278
    views
  • 2,463
    downloads
  • 282
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. C Shan Xu
  2. Kenneth J Hayworth
  3. Zhiyuan Lu
  4. Patricia Grob
  5. Ahmed M Hassan
  6. José G García-Cerdán
  7. Krishna K Niyogi
  8. Eva Nogales
  9. Richard J Weinberg
  10. Harald F Hess
(2017)
Enhanced FIB-SEM systems for large-volume 3D imaging
eLife 6:e25916.
https://doi.org/10.7554/eLife.25916

Share this article

https://doi.org/10.7554/eLife.25916

Categories and tags

Further reading

    1. Cell Biology

    Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease

    Yuki Date, Yukiko Sasazawa ... Shinji Saiki
    Research Article Updated

    The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including α-synuclein (αSyn) associated with the pathogenesis of Parkinson’s disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble αSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.

    1. Cancer Biology
    2. Cell Biology

    CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake

    Savvas Nikolaou, Amelie Juin ... Laura M Machesky
    Research Article Updated

    Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signalling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor 1. Overall, we implicate CYRI-B as a mediator of growth and signalling in pancreatic cancer, providing new insights into pathways controlling metastasis.

    1. Cell Biology
    2. Physics of Living Systems

    Cell Migration: Pump up the volume

    Qin Ni, Sean X Sun
    Insight

    An influx of water molecules can help immune cells called neutrophils to move to where they are needed in the body.